COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has substantially damaged the global economy and human health. The …

Abstract A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called
ARVAC CG was selected for a first in human clinical trial. Healthy male and female …

Since the start of the SARS-CoV-2 pandemic, several treatments have been proposed to
prevent the progression of the disease. Currently, three antiviral (molnupiravir, nirmaltrevir/r …

Although the chief of the World Health Organization (WHO) has declared the end of the
coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a …

The 2002 SARS outbreak, the 2019 emergence of COVID-19, and the continuing evolution
of immune-evading SARS-CoV-2 variants together highlight the need for a broadly …

We take a model-informed approach to the view that a global equitable access (GEA) to
Covid-19 vaccines is the key to bring this pandemic to an end. We show that the equitable …

Many respiratory diseases, including COVID-19, can be spread by aerosols expelled by
infected people when they cough, talk, sing, or exhale. Exposure to these aerosols indoors …

Conspiracies regarding vaccines are widely prevalent, with negative consequences on
health-seeking behaviors. The current study aimed to investigate the possible association …

While cancer immunotherapies have become central to treatment, challenges associated
with the ability of tumors to evade the immune system remain significant obstacles. At the …